- Agreement to broaden access, streamline logistics, and reduce variability associated with temperature-sensitive shipping of 3D tissue models, without cryopreservation
- Joint webinar to present trial performance data and best-practice workflows for global research community (4th 十二月, 10am EST)
Newcastle, UK, 2 十二月 2025: Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced an agreement with Labskin, a global leader in laboratory-grown human skin models used for research, testing and product development. The partnership follows a series of successful shipping trials, demonstrating Atelerix’s non-cryogenic preservation technology is able to maintain the structural integrity and viability of Labskin’s 3D constructs well beyond the traditional 72–96-hour transport window.
Labskin develops full-thickness human skin models for testing applications spanning skincare, cosmetics, healthcare, drug delivery and wound care. These physiologically-relevant models mimic the skin’s delicate microbiome, and therefore require careful shipping considerations. Through an initial Memorandum of Understanding (MoU), the agreement establishes a collaborative framework to validate and implement Atelerix’s hypothermic hydrogel technology for the extended-duration shipment of these advanced skin model systems. Extending the viable shipping period provides a significant logistical advantage for Labskin, reducing risk associated with customs delays and enabling reliable distribution to customers and further expansion across key global markets.
Atelerix’s patented hydrogel technology preserves membrane integrity and biological function at ambient or controlled temperatures, delivering a ready-to-use product upon arrival and avoiding the complications and resource demands of cold-chain transport. The MoU with Labskin follows in a series of strategic partnerships as the Company broadens global access to its preservation solutions across Europe, Africa, Asia and North America. Together, both companies will continue the collaborative optimisation of workflows and pursue joint opportunities for external engagement to demonstrate how next-generation preservation can transform the shipping and handling of complex biological materials.
Atelerix and Labskin will co-host a webinar on 十二月 4th, 10am EST to share performance data and demonstrate the benefits of cryo-free preservation for complex 3D tissue models -– enabling more reliable, sustainable, and efficient routes to market. Webinar can be watched on demand below.
Alastair Carrington, CEO, Atelerix, commented: “Labskin’s pioneering human skin models are already driving innovation across dermatology, microbiome research, cosmetics and therapeutic development. We are delighted that our preservation technology can help them reliably reach customers anywhere in the world. This MoU marks the start of a deeper collaboration, and we look forward to jointly showcasing the exciting potential of cryo-free logistics for complex tissue systems.”
Nicola Kingswell, Scientific Director, Labskin, added: “The increased delivery window provided by Atelerix’s technology has provided Labskin with the ability to ship our human 3D skin equivalents globally, without compromising on quality. It is a brilliant alternative to expensive controlled temperature shipping. The Atelerix team are a delight to collaborate with; friendly, responsive and knowledgeable, and I look forward to working closely with them for all our models as our partnership grows.”
完
编辑须知：
Alastair Carrington,
CEO, Atelerix
Nicola Kingswell,
Scientific Director, Labskin
如需高分辨率图片，请联系Zyme Communications。
如需了解更多信息，请联系：
阿拉斯泰尔·卡灵顿
Atelerix
电子邮件：alastair.carrington@atelerix.co.uk
Zyme Communications
杰克·布朗
Zyme Communications
电话：+44(0) 7759 162 147
电子邮件：jake.brown@zymecommunications.com
如需取消订阅 Zyme Communications 的新闻稿，请发送电子邮件至 info@zymecommunications.com。如需查看我们的隐私政策，请点击此处。
About Atelerix www.atelerix.co.uk
Atelerix 凭借其低温保存技术，正在开创一种独特的生物样本非冷冻储存和运输方案。
Atelerix 的水凝胶解决方案源自海藻，并从非洲四趾侏儒刺猬的冬眠机制中汲取灵感，从而消除了对昂贵且耗能的冷链供应的需求。这些水凝胶旨在通过物理封装技术包裹细胞并维持脂质膜的完整性，从而使细胞、组织和病毒能在室温下稳定保存长达两周。
To find out more, please visit www.atelerix.co.uk, and follow us on LinkedIn.
About Labskin Limited www.labskin.co.uk
Labskin Limited is a UK-based biotechnology company specialising in full-thickness human skin models for pharmaceutical, cosmetic, and clinical research. Its advanced 3D platforms offer realistic testing environments for evaluating treatments in vitro.
To learn more: www.labskin.co.uk
